Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

   19,500      
Direct Value   $6,843,889    

Indirect Value

   $130,455      
Total Shares   312,921      
Total Value   $6,974,344      


Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $982,888 Biocryst Pharmaceuticals Inc $409,803 Cti Biopharma Corporation $219,369 Biomarin Pharmaceutical Inc $5,231,829 Travere Therapeutics, Inc $982,888 Biocryst Pharmaceuticals Inc $409,803
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    4   
    5    

     Stock price went up :
    0   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   -4.0   
   1.5   
     Percentage Gain/Loss :
   -31.1%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2023-06-13 63,339 2019-03-12 0    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-04-01 4 AS $35.75 $29,024 D/D (805) 32,034 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-04-30 4 B $10.37 $15,825 D/D 1,526 33,560 2.74 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-02 4 S $37.75 $143,450 D/D (3,800) 44,865 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-02 4 OE $7.16 $20,764 D/D 2,900 36,460 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-06 4 S $37.75 $611,550 D/D (16,200) 28,665 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-06 4 OE $7.16 $142,348 D/D 12,205 48,665 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-07-07 4 A $0.00 $0 D/D 2,500 31,165 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-10-31 5 B $13.35 $16,506 D/D 1,236 32,401 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2009-04-30 4 A $10.93 $16,560 D/D 1,515 33,916 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2009-05-12 4 A $0.00 $0 D/D 12,000 45,916 0 -
BMRN Biomarin Pharmaceutical I... SVP, Chief Business Officer   •       –      –    2009-06-07 4 A $0.00 $0 D/D 2,500 48,416 0 -
BMRN Biomarin Pharmaceutical I... SVP, Chief Business Officer   •       –      –    2009-06-22 4 OE $0.00 $0 D/D 2,500 50,916 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2009-10-31 5 B $11.60 $4,119 D/D 355 51,271 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-02 4 S $21.00 $210,000 D/D (10,000) 41,271 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-03 4 S $21.00 $210,000 D/D (10,000) 31,271 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-04 4 S $21.50 $107,500 D/D (5,000) 50,361 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-05 4 S $21.95 $140,831 D/D (6,416) 43,945 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-08 4 OE $7.16 $172,484 D/D 24,090 55,361 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-08 4 S $22.11 $532,526 D/D (24,090) 19,855 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-04-30 4 A $11.64 $17,827 D/D 1,532 21,387 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-05-12 4 A $0.00 $0 D/D 11,200 32,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-05-22 4 OE $0.00 $0 D/D 2,500 35,087 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-06-07 4 OE $0.00 $0 D/D 2,500 37,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-09-08 4 OE $11.74 $410,900 D/D 35,000 72,587 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-09-08 4 S $22.00 $770,000 D/D (35,000) 37,587 0 -
  169  Records found
  1   2  3   4   5   6   7      
  Page 2 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us